GSA Capital Partners’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,680
| Closed | -$224K | – | 2143 |
|
|
2025
Q1 | $224K | Buy |
+5,680
| New | +$224K | 0.02% | 1340 |
|
|
2024
Q4 | – | Sell |
-10,987
| Closed | -$257K | – | 2029 |
|
|
2024
Q3 | $257K | Sell |
10,987
-13,465
| -55% | -$315K | 0.02% | 1302 |
|
|
2024
Q2 | $435K | Buy |
+24,452
| New | +$435K | 0.03% | 1053 |
|
|
2023
Q4 | – | Sell |
-22,857
| Closed | -$191K | – | 1923 |
|
|
2023
Q3 | $191K | Sell |
22,857
-48,661
| -68% | -$407K | 0.02% | 1293 |
|
|
2023
Q2 | $1.78M | Buy |
71,518
+38,107
| +114% | +$947K | 0.18% | 86 |
|
|
2023
Q1 | $503K | Sell |
33,411
-98,482
| -75% | -$1.48M | 0.05% | 718 |
|
|
2022
Q4 | $1.56M | Buy |
131,893
+92,427
| +234% | +$1.09M | 0.19% | 57 |
|
|
2022
Q3 | $234K | Sell |
39,466
-5,815
| -13% | -$34.5K | 0.03% | 1109 |
|
|
2022
Q2 | $192K | Sell |
45,281
-17,903
| -28% | -$75.9K | 0.03% | 1082 |
|
|
2022
Q1 | $601K | Buy |
63,184
+52,440
| +488% | +$499K | 0.08% | 422 |
|
|
2021
Q4 | $204K | Buy |
+10,744
| New | +$204K | 0.03% | 1217 |
|
|
2021
Q1 | – | Sell |
-6,442
| Closed | -$335K | – | 1490 |
|
|
2020
Q4 | $335K | Buy |
+6,442
| New | +$335K | 0.05% | 678 |
|
|
2019
Q4 | – | Sell |
-61,115
| Closed | -$343K | – | 1724 |
|
|
2019
Q3 | $343K | Buy |
+61,115
| New | +$343K | 0.05% | 799 |
|